710P Neoadjuvant tislelizumab for resectable recurrent hepatocellular carcinoma: A non-randomized control, phase II trial (TALENT)
S. Chen, Y. Wang, Wenxuan Xie, S. Shen, Sui Peng, Ming Kuang
Topics & Concepts
MedicineHepatocellular carcinomaOncologyRandomized controlled trialNeoadjuvant therapyInternal medicineCancerBreast cancerHepatocellular Carcinoma Treatment and PrognosisLiver physiology and pathologyPancreatic and Hepatic Oncology Research